Abstract
Changes in the biomechanical properties of the human cornea play an important role in the pathogenesis of corneal ectatic diseases. Many different pathological conditions in the cornea may reduce its biomechanical resistance. Corneal collagen cross-linking (CXL) has emerged as a promising technique to slow or even to stop the progression of ectasia. In this procedure, riboflavin (vitamin B2) is administered in conjunction with ultraviolet A light (UVA, 365 nm). This interaction causes the formation of reactive oxygen species, leading to additional covalent bonds between collagen molecules, with consequent biomechanical stiffening of the cornea. Although this method is not yet accepted as an evidence-based treatment of corneal ectasia, the results of prospective, randomised studies of CXL used in the treatment of this pathological entity show significant changes in the properties of corneal tissue. This procedure is currently the only aetiopathogenetic treatment of ectatic corneas that can delay or stop the process of cornea destabilisation, reducing the necessity for keratoplasty. Despite promising results, CXL is associated with issues that include long-term safety and duration of the stabilising effect. The chapter describes briefly standard “Dresden protocol” and also accelerated mode of CXL treatment. The attention of the chapter is turned to the importance of medical history of the patient, evidence of the progression of keratoconus and possible complications after the procedure.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135:620–7.
Raiskup F, Theuring A, Pillunat LE, et al. Corneal collagen crosslinking with riboflavin and ultraviolet-A light in progressive keratoconus: ten-year results. J Cataract Refract Surg. 2015;41:41–6.
Schumacher S, Oeftiger L, Mrochen M. Equivalence of biomechanical changes induced by rapid and standard corneal cross-linking, using riboflavin and ultraviolet radiation. Invest Ophthalmol Vis Sci. 2011;52:9048–52. https://doi.org/10.1167/iovs.11-7818.
Krueger RR, Herekar S, Spoerl E. First proposed efficacy study of high versus standard irradiance and fractionated riboflavin/ultraviolet a cross-linking with equivalent energy exposure. Eye Contact Lens. 2014;40:353–7. https://doi.org/10.1097/icl.0000000000000095.
Hammer A, Richoz O, Arba Mosquera S, et al. Corneal biomechanical properties at different corneal cross-linking (CXL) irradiances. Invest Ophthalmol Vis Sci. 2014;55:2881–4. https://doi.org/10.1167/iovs.13-13748.
Wernli J, Schumacher S, Spoerl E, et al. The efficacy of corneal cross-linking shows a sudden decrease with very high intensity UV light and short treatment time. Invest Ophthalmol Vis Sci. 2013;54:1176–80. https://doi.org/10.1167/iovs.12-11409.
Richoz O, Hammer A, Tabibian D, et al. The biomechanical effect of corneal collagen cross-linking (CXL) with riboflavin and UV-A is oxygen dependent. Transl Vision Sci Technol. 2013;2:6. https://doi.org/10.1167/tvst.2.7.6.
Caporossi A, Mazzotta C, Baiocchi S, et al. Age-related long-term functional results after riboflavin UV A corneal cross-linking. J Ophthalmol. 2011;2011:608041. https://doi.org/10.1155/2011/608041.
Chatzis N, Hafezi F. Progression of keratoconus and efficacy of pediatric corrected corneal collagen cross-linking in children and adolescents. J Refract Surg (Thorofare, NJ: 1995). 2012;28:753–8. https://doi.org/10.3928/1081597x-20121011-01.
Spoerl E, Zubaty V, Terai N, et al. Influence of high-dose cortisol on the biomechanics of incubated porcine corneal strips. J Refract Surg. 2009;25:S794–8. https://doi.org/10.3928/1081597x-20090813-06.
Spoerl E, Zubaty V, Raiskup-Wolf F, et al. Oestrogen-induced changes in biomechanics in the cornea as a possible reason for keratectasia. Br J Ophthalmol. 2007;91:1547–50. https://doi.org/10.1136/bjo.2007.124388.
Bilgihan K, Hondur A, Sul S, et al. Pregnancy-induced progression of keratoconus. Cornea. 2011;30:991–4. https://doi.org/10.1097/ICO.0b013e3182068adc.
Gatzioufas Z, Panos GD, Gkaragkani E, et al. Recurrence of keratoconus after deep anterior lamellar keratoplasty following pregnancy. Int J Ophthalmol. 2017;10:1011–3. https://doi.org/10.18240/ijo.2017.06.28.
Tabibian D, Tejada BMD, Gatzioufas Z, et al. Pregnancy-induced changes in corneal biomechanics and topography are thyroid hormone related. Am J Ophthalmol. 2017; https://doi.org/10.1016/j.ajo.2017.10.001.
Hafezi F, Iseli HP. Pregnancy-related exacerbation of iatrogenic keratectasia despite corneal collagen crosslinking. J Cataract Refract Surg. 2008;34:1219–21. https://doi.org/10.1016/j.jcrs.2008.02.036.
Thanos S, Oellers P, Meyer Zu Horste M, et al. Role of thyroxine in the development of keratoconus. Cornea. 2016;35:1338–46. https://doi.org/10.1097/ico.0000000000000988.
Kappmeyer K, Lanzl IM. Intra-ocular pressure during and after playing high and low resistance wind instruments. Ophthalmologe. 2010;107:41–6.
McMonnies CW. The possible significance of the baropathic nature of keratectasias. Clin Exp Optom. 2013;96:197–200.
Gomes JAP, Tan D, Rapuano CJ, et al. Global consensus on keratoconus and ectatic diseases. Cornea. 2015;34:359–69. https://doi.org/10.1097/ico.0000000000000408.
Kuo IC, Broman A, Pirouzmanesh A, et al. Is there an association between diabetes and keratoconus? Ophthalmology. 2006;113:184–90. https://doi.org/10.1016/j.ophtha.2005.10.009.
Seiler T, Huhle S, Spoerl E, et al. Manifest diabetes and keratoconus: a retrospective case-control study. Graefes Arch Clin Exp Ophthalmol. 2000;238:822–5.
Morita A. Tobacco smoke causes premature skin aging. J Dermatol Sci. 2007;48:169–75. https://doi.org/10.1016/j.jdermsci.2007.06.015.
Mahmud A, Feely J. Effect of smoking on arterial stiffness and pulse pressure amplification. Hypertension (Dallas, Tex: 1979). 2003;41:183–7.
Spoerl E, Raiskup-Wolf F, Kuhlisch E, et al. Cigarette smoking is negatively associated with keratoconus. J Refract Surg. 2008;24:S737–40.
Vinciguerra P, Albe E, Trazza S, et al. Refractive, topographic, tomographic, and aberrometric analysis of keratoconic eyes undergoing corneal cross-linking. Ophthalmology. 2009;116:369–78. https://doi.org/10.1016/j.ophtha.2008.09.048.
Hersh PS, Greenstein SA, Fry KL. Corneal collagen crosslinking for keratoconus and corneal ectasia: one-year results. J Cataract Refract Surg. 2011;37:149–60.
Duncan JK, Belin MW, Borgstrom M. Assessing progression of keratoconus: novel tomographic determinants. Eye Vision (London, England). 2016;3:6. https://doi.org/10.1186/s40662-016-0038-6.
Belin MW, Duncan JK. Keratoconus: the ABCD grading system. Klin Monatsbl Augenheilkd. 2016;233:701–7. https://doi.org/10.1055/s-0042-100626.
Raiskup-Wolf F, Hoyer A, Spoerl E, et al. Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: long-term results. J Cataract Refract Surg. 2008;34:796–801.
Wittig-Silva C, Chan E, Islam FM, et al. A randomized, controlled trial of corneal collagen cross-linking in progressive keratoconus: three-year results. Ophthalmology. 2014;121:812–21.
O’Brart DP, Patel P, Lascaratos G, et al. Corneal cross-linking to halt the progression of keratoconus and corneal ectasia: seven-year follow-up. Am J Ophthalmol. 2015;160:1154–63.
Sharma N, Suri K, Sehra SV, et al. Collagen cross-linking in keratoconus in Asian eyes: visual, refractive and confocal microscopy outcomes in a prospective randomized controlled trial. Int Ophthalmol. 2015;35:827–32. https://doi.org/10.1007/s10792-015-0054-x.
Lang SJ, Messmer EM, Geerling G, et al. Prospective, randomized, double-blind trial to investigate the efficacy and safety of corneal cross-linking to halt the progression of keratoconus. BMC Ophthalmol. 2015;15:78.
Kymionis GD, Tsoulnaras KI, Liakopoulos DA, et al. Corneal stromal demarcation line depth following standard and a modified high intensity corneal cross-linking protocol. J Refract Surg (Thorofare, NJ: 1995). 2016;32:218–22. https://doi.org/10.3928/1081597x-20160216-01.
Ozgurhan EB, Akcay BIS, Kurt T, et al. Accelerated corneal collagen cross-linking in thin keratoconic corneas. J Refract Surg (Thorofare, NJ: 1995). 2015;31:386–90. https://doi.org/10.3928/1081597x-20150521-11.
Ng ALK, Chan TCY, Lai JSM, et al. Comparison of the central and peripheral corneal stromal demarcation line depth in conventional versus accelerated collagen cross-linking. Cornea. 2015;34:1432–6. https://doi.org/10.1097/ico.0000000000000626.
Tomita M, Mita M, Huseynova T. Accelerated versus conventional corneal collagen crosslinking. J Cataract Refract Surg. 2014;40:1013–20. https://doi.org/10.1016/j.jcrs.2013.12.012.
Ozgurhan EB, Sezgin Akcay BI, Yildirim Y, et al. Evaluation of corneal stromal demarcation line after two different protocols of accelerated corneal collagen cross-linking procedures using anterior segment optical coherence tomography and confocal microscopy. J Ophthalmol. 2014;2014:981893. https://doi.org/10.1155/2014/981893.
Kymionis GD, Tsoulnaras KI, Grentzelos MA, et al. Evaluation of corneal stromal demarcation line depth following standard and a modified-accelerated collagen cross-linking protocol. Am J Ophthalmol. 2014;158:671–675.e671. https://doi.org/10.1016/j.ajo.2014.07.005.
Kymionis GD, Tsoulnaras KI, Grentzelos MA, et al. Corneal stroma demarcation line after standard and high-intensity collagen crosslinking determined with anterior segment optical coherence tomography. J Cataract Refract Surg. 2014;40:736–40. https://doi.org/10.1016/j.jcrs.2013.10.029.
Kymionis GD, Tsoulnaras KI, Liakopoulos DA, et al. Corneal stromal demarcation line determined with anterior segment optical coherence tomography following a very high intensity corneal collagen cross-linking protocol. Cornea. 2015;34:664–7. https://doi.org/10.1097/ico.0000000000000427.
Kymionis GD, Grentzelos MA, Kankariya VP, et al. Safety of high-intensity corneal collagen crosslinking. J Cataract Refract Surg. 2014;40:1337–40. https://doi.org/10.1016/j.jcrs.2013.11.041.
Hashemi H, Fotouhi A, Miraftab M, et al. Short-term comparison of accelerated and standard methods of corneal collagen crosslinking. J Cataract Refract Surg. 2015;41:533–40. https://doi.org/10.1016/j.jcrs.2014.07.030.
Choi M, Kim J, Kim EK, et al. Comparison of the conventional dresden protocol and accelerated protocol with higher ultraviolet intensity in corneal collagen cross-linking for keratoconus. Cornea. 2017;36:523–9. https://doi.org/10.1097/ico.0000000000001165.
Kymionis GD, Portaliou DM, Bouzoukis DI, et al. Herpetic keratitis with iritis after corneal crosslinking with riboflavin and ultraviolet A for keratoconus. J Cataract Refract Surg. 2007;33:1982–4. https://doi.org/10.1016/j.jcrs.2007.06.036.
Pollhammer M, Cursiefen C. Bacterial keratitis early after corneal crosslinking with riboflavin and ultraviolet-A. J Cataract Refract Surg. 2009;35:588–9. https://doi.org/10.1016/j.jcrs.2008.09.029.
Rama P, Di Matteo F, Matuska S, et al. Acanthamoeba keratitis with perforation after corneal crosslinking and bandage contact lens use. J Cataract Refract Surg. 2009;35:788–91. https://doi.org/10.1016/j.jcrs.2008.09.035.
Zamora KV, Males JJ. Polymicrobial keratitis after a collagen cross-linking procedure with postoperative use of a contact lens: a case report. Cornea. 2009;28:474–6. https://doi.org/10.1097/ICO.0b013e31818d381a.
Koller T, Mrochen M, Seiler T. Complication and failure rates after corneal crosslinking. J Cataract Refract Surg. 2009;35:1358–62.
Seiler T, Hafezi F. Corneal cross-linking-induced stromal demarcation line. Cornea. 2006;25:1057–9. https://doi.org/10.1097/01.ico.0000225720.38748.58.
Herrmann CI, Hammer T, Duncker GI. Hazeformation (corneal scarring) after cross-linking therapy in keratoconus. Ophthalmologe. 2008;105:485–7.
Mazzotta C, Traversi C, Baiocchi S, et al. Corneal healing after riboflavin ultraviolet-A collagen cross-linking determined by confocal laser scanning microscopy in vivo: early and late modifications. Am J Ophthalmol. 2008;146:527–33. https://doi.org/10.1016/j.ajo.2008.05.042.
Mazzotta C, Balestrazzi A, Baiocchi S, et al. Stromal haze after combined riboflavin-UVA corneal collagen cross-linking in keratoconus: in vivo confocal microscopic evaluation. Clin Exp Ophthalmol. 2007;35:580–2.
Greenstein SA, Fry KL, Bhatt J, et al. Natural history of corneal haze after collagen crosslinking for keratoconus and corneal ectasia: Scheimpflug and biomicroscopic analysis. J Cataract Refract Surg. 2010;36:2105–14.
Raiskup F, Hoyer A, Spoerl E. Permanent corneal haze after riboflavin-UVA-induced cross-linking in keratoconus. J Refract Surg. 2009;25:S824–8.
Kymionis GD, Portaliou DM, Diakonis VF, et al. Corneal collagen cross-linking with riboflavin and ultraviolet-A irradiation in patients with thin corneas. Am J Ophthalmol. 2012;153:24–8. https://doi.org/10.1016/j.ajo.2011.05.036.
Gokhale NS. Corneal endothelial damage after collagen cross-linking treatment. Cornea. 2011;30:1495–8. https://doi.org/10.1097/ICO.0b013e31820687f7.
Bagga B, Pahuja S, Murthy S, et al. Endothelial failure after collagen cross-linking with riboflavin and UV-A: case report with literature review. Cornea. 2012;31:1197–200. https://doi.org/10.1097/ICO.0b013e31823cbeb1.
Labiris G, Kaloghianni E, Koukoula S, et al. Corneal melting after collagen cross-linking for keratoconus: a case report. J Med Case Rep. 2011;5:152. https://doi.org/10.1186/1752-1947-5-152.
Gokhale NS, Vemuganti GK. Diclofenac-induced acute corneal melt after collagen crosslinking for keratoconus. Cornea. 2010;29:117–9. https://doi.org/10.1097/ICO.0b013e3181a06c31.
Faschinger C, Kleinert R, Wedrich A. Corneal melting in both eyes after simultaneous corneal cross-linking in a patient with keratoconus and Down syndrome. Ophthalmologe. 2010;107:951–2, 954–5.
Eberwein P, Auw-Hadrich C, Birnbaum F, et al. Corneal melting after cross-linking and deep lamellar keratoplasty in a keratoconus patient. Klin Monatsbl Augenheilkd. 2008;225:96–8. https://doi.org/10.1055/s-2008-1027128.
Craig JA, Mahon J, Yellowlees A, et al. Epithelium-off photochemical corneal collagen cross-linkage using riboflavin and ultraviolet a for keratoconus and keratectasia: a systematic review and meta-analysis. Ocul Surf. 2014;12:202–14. https://doi.org/10.1016/j.jtos.2014.05.002.
Pron G, Ieraci L, Kaulback K. Collagen cross-linking using riboflavin and ultraviolet-a for corneal thinning disorders: an evidence-based analysis. Ont Health Technol Assess Ser. 2011;11:1–89.
Sandvik GF, Thorsrud A, Raen M, et al. Does corneal collagen cross-linking reduce the need for keratoplasties in patients with keratoconus? Cornea. 2015;34:991–5.
Godefrooij DA, Gans R, Imhof SM, et al. Nationwide reduction in the number of corneal transplantations for keratoconus following the implementation of cross-linking. Acta Ophthalmol. 2016;94:675–8.
Rebenitsch RL, Kymes SM, Walline JJ, et al. The lifetime economic burden of keratoconus: a decision analysis using a markov model. Am J Ophthalmol. 2011;151:768–73.e762. https://doi.org/10.1016/j.ajo.2010.10.034.
Salmon HA, Chalk D, Stein K, et al. Cost effectiveness of collagen crosslinking for progressive keratoconus in the UK NHS. Eye (London, England). 2015;29:1504–11.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Raiskup, F. (2019). Epithelium-Off Corneal Cross-Linking. In: Barbara, A. (eds) Controversies in the Management of Keratoconus . Springer, Cham. https://doi.org/10.1007/978-3-319-98032-4_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-98032-4_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-98031-7
Online ISBN: 978-3-319-98032-4
eBook Packages: MedicineMedicine (R0)